Polydatin reduces Staphylococcus aureus lipoteichoic acid-induced injury by attenuating reactive oxygen species generation and TLR2-NFκB signalling

J Cell Mol Med. 2017 Nov;21(11):2796-2808. doi: 10.1111/jcmm.13194. Epub 2017 May 19.

Abstract

Staphylococcus aureus (S. aureus) causes severe inflammation in various infectious diseases, leading to high mortality. The clinical application of antibiotics has gained a significant curative effect. However, it has led to the emergence of various resistant bacteria. Therefore, in this study, we investigated the protective effect of polydatin (PD), a traditional Chinese medicine extract, on S. aureus lipoteichoic acid (LTA)-induced injury in vitro and in vivo. First, a significant improvement in the pathological conditions of PD in vivo was observed, suggesting that PD had a certain protective effect on LTA-induced injury in a mouse model. To further explore the underlying mechanisms of this protective effect of PD, LTA-induced murine macrophages were used in this study. The results have shown that PD could reduce the NF-κB p65, and IκBα phosphorylation levels increased by LTA, resulting in a decrease in the transcription of pro-inflammatory factors, such as TNF-α, IL-1β and IL-6. However, LTA can not only activate NF-κB through the recognition of TLR2 but also increase the level of intracellular reactive oxygen species (ROS), thereby activating NF-κB signalling. We also detected high levels of ROS that activate caspases 9 and 3 to induce apoptosis. In addition, using a specific NF-κB inhibitor that could attenuate apoptosis, namely NF-κB p65, acted as a pro-apoptotic transcription factor in LTA-induced murine macrophages. However, PD could inhibit the generation of ROS and NF-κB p65 activation, suggesting that PD suppressed LTA-induced injury by attenuating ROS generation and TLR2-NFκB signalling.

Keywords: ROS; NF-κB; apoptosis; inflammation.

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Cell Survival / drug effects
  • Endometriosis / chemically induced
  • Endometriosis / drug therapy*
  • Endometriosis / genetics
  • Endometriosis / immunology
  • Female
  • Gene Expression Regulation
  • Glucosides / pharmacology*
  • I-kappa B Proteins / genetics
  • I-kappa B Proteins / immunology
  • Interleukin-1beta / genetics
  • Interleukin-1beta / immunology
  • Interleukin-6 / genetics
  • Interleukin-6 / immunology
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / isolation & purification
  • Lipopolysaccharides / toxicity
  • Mice
  • Mice, Inbred BALB C
  • Oxidative Stress / drug effects
  • Protective Agents / pharmacology*
  • RAW 264.7 Cells
  • Reactive Oxygen Species / antagonists & inhibitors*
  • Reactive Oxygen Species / immunology
  • Reactive Oxygen Species / metabolism
  • Signal Transduction
  • Staphylococcus aureus / chemistry
  • Stilbenes / pharmacology*
  • Teichoic Acids / antagonists & inhibitors
  • Teichoic Acids / isolation & purification
  • Teichoic Acids / toxicity
  • Toll-Like Receptor 2 / genetics*
  • Toll-Like Receptor 2 / immunology
  • Transcription Factor RelA / genetics*
  • Transcription Factor RelA / immunology
  • Uterus / drug effects
  • Uterus / immunology
  • Uterus / pathology

Substances

  • Antioxidants
  • Glucosides
  • I-kappa B Proteins
  • IL1B protein, mouse
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • Protective Agents
  • Reactive Oxygen Species
  • Stilbenes
  • Teichoic Acids
  • Tlr2 protein, mouse
  • Toll-Like Receptor 2
  • Transcription Factor RelA
  • interleukin-6, mouse
  • lipoteichoic acid
  • polydatin

Associated data

  • GENBANK/NM_011905.3
  • GENBANK/NM_013693.3
  • GENBANK/NM_008361.4
  • GENBANK/NM_031168.1
  • GENBANK/NM_001289726.1